Precision Optics Corporation, Inc. (POCI)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 10 | 11 | 16 | 21 | 19 | 19 | 29 | 30 |
| Operating profit | $m | -6 | -5 | ||||||
| Net profit | $m | -1 | -0 | -1 | -0 | -3 | -6 | -5 | -3 |
| EPS reported | $ | -0.85 | -0.66 | ||||||
| Operating cashflow per share | $ | -0.52 | -0.19 | ||||||
| Capex per share | $ | 0.03 | 0.05 | ||||||
| FCF per share | $ | -0.56 | -0.24 | ||||||
| Free cash flow | $m | -4 | -2 | ||||||
| Net debt | $m | 0 | -9 | ||||||
| Book value equity | $m | 12 | 20 | ||||||
| Book value per share | $ | 1.81 | 2.58 | ||||||
| Number of shares | m | 6.79 | 7.79 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 2.71 | 1.65 | ||||||
| P/S LTM | x | 1.74 | 1.15 | ||||||
| P/FCF LTM | x | -8.82 | -17.77 | ||||||
| EV/EBITDA LTM | x | -6.28 | -7.47 | ||||||
| EV/Sales LTM | x | 1.76 | 1.44 | ||||||
| Earnings Yield LTM | % | -17.37% | -14.42% | ||||||
| FCF Yield | % | -11.34% | -5.63% | ||||||
| Quality | |||||||||
| ROE | % | -47.15% | -37.47% | ||||||
| ROIC | % | -38.83% | -19.51% | ||||||
| Operating margin | % | -29.08% | -16.44% | ||||||
| Gross margin | % | +17.83% | +13.85% | ||||||
| FCF/Sales | % | -19.77% | -6.47% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -0.07% | +51.48% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -1.85 | -0.44 | ||||||
| Net Debt/EBITDA | x | -0.05 | 1.43 | ||||||
| EBIT/Net interest | x | -24.45 | -29.75 | ||||||
| Net debt/market cap | % | +5.61% | +2.99% | ||||||
| Net debt/Equity | x | 0.01 | -0.46 | ||||||
| Gross debt/equity | x | 0.17 | 0.21 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Precision Optics Corporation, Inc. (POCI)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free